Wolfe Research Downgrades Soleno Therapeutics to Peer Perform

Benzinga Newsdesk www.benzinga.com Negative 94.3%

Neg 94.3% Neu 0% Pos 0%

Wolfe Research analyst Kalpit Patel downgrades Soleno Therapeutics (NASDAQ:SLNO) from Outperform to Peer Perform.

Comments

No comments yet. Be the first!